Evidence map›Paper›PMID 25850055›Full record

ArticleNature biotechnology2015

Are the gene-patent storm clouds dissipating? A global snapshot.

Johnathon Liddicoat, Tess Whitton, Dianne Nicol

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Johnathon LiddicoatCentre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia.
Tess WhittonCentre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia.
Dianne NicolCentre for Law and Genetics, Faculty of Law, University of Tasmania, Hobart, Tasmania, Australia.ORCID 0000000265532839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In genetic diagnostics testing, what are the boundaries of the global patent problem, and is there a real risk that patents and licensing practices could impede access to tests?

Indexed as

InternationalityCytogeneticsGeneticsGenetic TestingPatents as TopicUnited States

Identifiers

PMID25850055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.